PMP Series | Clonidine in Maine’s Carceral Setting: Pharmacology, Prescribing Practices, and Safety Considerations

In this webinar, Jessika Morin, MD, and Nicolette Centanni, PharmD, will provide clinicians with a review of clonidine, including its pharmacological properties, mechanism of action, and key prescribing considerations across a range of clinical indications. Special attention will be given to the use of clonidine in patients with substance use disorder, including its role in managing withdrawal symptoms associated with opioid and alcohol use disorders and important safety considerations for this patient population. Use of clonidine for patients with justice-system involvement as well as in the community will be discussed.

Objectives:

  • Describe pharmacological properties of clonidine as an alpha-2 adrenergic agonist
  • Discuss evidence-based prescribing practices for clonidine across approved and off-label indications
  • Discuss the role of clonidine in the management of patients with substance use disorder (SUD)

Speakers

  • Jessika Morin MD

    Statewide Medical Director of Maine, Wellpath

  • Nicolette Centanni PharmD BCPS BCGP BCPP
    Nicolette Centanni PharmD BCPS BCGP BCPP

    Nicolette Centanni, PharmD, BCPS, BCGP, BCPP is a clinical pharmacist at Mainehealth Maine Medical Center Portland Campus focusing on psychiatry and addiction medicine and Adjunct Clinical Assistant Professor of Psychiatry in the Tufts University School of Medicine. She graduated from MCPHS in Worcester, MA in 2004 and has been practicing at MHMMCP since 2009. Dr. Centanni is triple board certified as a Pharmacotherapy Specialist (BCPS), a Geriatric Pharmacist (BCGP) and a Psychiatric Pharmacist (BCPP). She is passionate about the care of people with substance use disorder and is committed to increasing access to evidence-based care in all settings.

Date

Jun 25 2026
Expired!

Time

12:00 pm - 1:00 pm

Location

Webinar

More Info

REGISTER
Maine Substance Use Disorders Learning Community

Organizer

Maine Substance Use Disorders Learning Community